Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
17 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//MICROBIOLOGY//JOURNAL OF BACTERIOLOGY | 725599 |
213 | 3 | TELOMERASE//TELOMERE//G QUADRUPLEX | 51465 |
456 | 2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//OLIGONUCLEOTIDES//PEPTIDE NUCLEIC ACID | 16291 |
2367 | 1 | ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT//ANTISENSE OLIGONUCLEOTIDES//ANTISENSE RESEARCH AND DEVELOPMENT | 2305 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | journal | 601963 | 6% | 34% | 128 |
2 | ANTISENSE OLIGONUCLEOTIDES | authKW | 365108 | 9% | 13% | 209 |
3 | ANTISENSE RESEARCH AND DEVELOPMENT | journal | 344487 | 2% | 60% | 42 |
4 | ANTISENSE | authKW | 312650 | 10% | 10% | 221 |
5 | PHOSPHOROTHIOATE | authKW | 244370 | 3% | 24% | 73 |
6 | OLIGONUCLEOTIDES | authKW | 207055 | 9% | 7% | 207 |
7 | PHOSPHOROTHIOATE OLIGONUCLEOTIDES | authKW | 100458 | 1% | 35% | 21 |
8 | OLIGODEOXYNUCLEOTIDE | authKW | 98491 | 2% | 14% | 52 |
9 | ANTISENSE OLIGODEOXYNUCLEOTIDE | authKW | 96984 | 2% | 13% | 55 |
10 | C 5 PROPYNE | authKW | 54686 | 0% | 100% | 4 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 6368 | 44% | 0% | 1022 |
2 | Medicine, Research & Experimental | 2490 | 13% | 0% | 306 |
3 | Pharmacology & Pharmacy | 2166 | 20% | 0% | 455 |
4 | Biotechnology & Applied Microbiology | 2135 | 14% | 0% | 324 |
5 | Chemistry, Medicinal | 557 | 5% | 0% | 123 |
6 | Biochemical Research Methods | 413 | 5% | 0% | 124 |
7 | Oncology | 411 | 9% | 0% | 208 |
8 | Virology | 255 | 3% | 0% | 70 |
9 | Biophysics | 212 | 5% | 0% | 105 |
10 | Chemistry, Organic | 109 | 5% | 0% | 111 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CHEM G 838 | 42719 | 0% | 63% | 5 |
2 | ASTON GENE BASED THER EUT | 27343 | 0% | 100% | 2 |
3 | CVN 10 | 27343 | 0% | 100% | 2 |
4 | JIANGXI OAI GEMEINSAMES | 27343 | 0% | 100% | 2 |
5 | STELLAR CHANCE S 513B | 27343 | 0% | 100% | 2 |
6 | CHIM THER EUT RADIOPHARM | 18227 | 0% | 67% | 2 |
7 | GRP DRUG TARGETING DELIVERY POORLY STABLE CPDS | 18227 | 0% | 67% | 2 |
8 | IFR PATHOL INFECT INSERM U386 | 18227 | 0% | 67% | 2 |
9 | UCL 7541 | 18227 | 0% | 67% | 2 |
10 | AK PROF G JONG | 13671 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 601963 | 6% | 34% | 128 |
2 | ANTISENSE RESEARCH AND DEVELOPMENT | 344487 | 2% | 60% | 42 |
3 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 37848 | 5% | 2% | 114 |
4 | NUCLEIC ACID THERAPEUTICS | 24198 | 1% | 8% | 22 |
5 | ANTI-CANCER DRUG DESIGN | 14690 | 1% | 4% | 26 |
6 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 13114 | 1% | 3% | 29 |
7 | OLIGONUCLEOTIDES | 11407 | 1% | 6% | 15 |
8 | NUCLEIC ACIDS RESEARCH | 9098 | 7% | 0% | 166 |
9 | ANTIVIRAL RESEARCH | 2143 | 1% | 1% | 24 |
10 | JOURNAL OF DRUG TARGETING | 1622 | 1% | 1% | 14 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |